Dental anxiety (DA) is highly prevalent among children undergoing dental procedures, with 50-80% experiencing fear that disrupts treatment and exacerbates oral health outcomes. While nitrous oxide (Nâ‚‚O) sedation is widely used for its anxiolytic properties, evidence remains limited regarding its standardized efficacy in reducing pediatric fear and anxiety scores.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
MDAS
Timeframe: From enrollment to the end of treatment at 1 week
Behavioral Observation Scale
Timeframe: From enrollment to the end of treatment at 1 week
CFSS-DS
Timeframe: From enrollment to the end of treatment at 1 week